Categories


CEO Mark Capone talks about the primary challenges facing the molecular diagnostics industry and Myriad’s role as an industry leader in…

Continue Reading

CEO Mark Capone describes Myriad’s efforts to ensure that patients have access to our tests because we understand how the tests…

Continue Reading

CEO Mark Capone explains what personalized medicine is and the role of genetics in tailoring and improving treatments for individual patients.…

Continue Reading

Myriad CEO Mark Capone notes that the current healthcare system in the U.S. is one of the most effective in the…

Continue Reading

CEO Mark Capone talks about the importance we place on research collaborations and the role molecular diagnostics play in tailoring treatments…

Continue Reading

CEO Mark Capone describes Myriad’s innovative role in the development of molecular diagnostics. “We actually invented the research- based, education-centric business…

Continue Reading


CEO Mark Capone tells the story of one patient and how genetic testing might have saved her life, as well as…

Continue Reading

CEO Mark Capone describes the unique Myriad culture and what the “DNA of a Myriadian” means to us. “We recognize that…

Continue Reading